Senate Bill 1897
116th Congress(2019-2020)
A bill to establish a process for updating the labeling of certain drugs with outdated labeling.
Introduced
Introduced in Senate on Jun 19, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1897
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.
June 19, 2019
06/19/2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
06/19/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 1:51:01 PM